Yahoo Finance

Nextbiomedical Publishes Landmark Study in GUT Demonstrating Nexpowder™ Significantly Reduces Rebleeding After Endoscopic Hemostasis

SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...
조선일보

Next Biomedical ships hemostatic agent Nexpowder to Japan for endoscopy use

Next Biomedical announced on the 17th that it has completed the first shipment of its hemostatic agent for endoscopy, Nexpowder, to Japan. Nexpowder received product approval from the Pharmaceuticals ...
아시아경제

[Click eStock] "NextBio, FDA Approval Expected for Major Indication in Second Half of This Year"

LS Securities forecasted on the 22nd that sales of Nextbiomedical will rapidly increase as the market penetration rate of NexPowder rises. Jo Eun-ae, a researcher at LS Securities, explained, ...
Becker's ASC

FDA clears Medtronic gastrointestinal bleeding solution

Nexpowder is a noncontact, nonthermal and nontraumatic powder that can treat upper gastrointestinal bleeding, according to a Sept. 28 news release from the company shared with Becker’s. Seventy-five ...
Medscape

FDA Clears Nexpowder Endoscopic Hemostasis System

The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...
Becker's ASC

8 endoscopy updates in the last 30 days

From a partnership with the VA to a new endoscope debut, here are eight endoscopy updates Becker’s has reported on in the last 30 days. 1. Medtronic will install 115 GI Genius AI endoscopy modules at ...